CRESCENT BIOPHARMA, INC.
CBIO
20 insider filings · Latest: Sep 16, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | Sep 18 8:03 PM | Ryan LynchTreasurer, Senior Vice President of Finance and Chief Accounting Officer. | Sale | 240 | $17.90 | $4.3K | 13,631(D) | View → |
| Sep 16, 2026 | Sep 18 8:03 PM | Jan PinkasChief Scientific Officer | Sale | 658 | $17.90 | $11.8K | 21,581(D) | View → |
| Sep 16, 2026 | Sep 18 8:02 PM | Ellie Eunkyung ImChief Medical Officer | Sale | 623 | $17.90 | $11.2K | 21,446(D) | View → |
| Sep 16, 2026 | Sep 18 8:02 PM | Richard William ScalzoChief Financial Officer | Sale | 568 | $17.90 | $10.2K | 19,730(D) | View → |
| Sep 16, 2026 | Sep 18 8:02 PM | Barbara Harlin BisphamGeneral Counsel and Corporate Secretary. | Sale | 620 | $17.90 | $11.1K | 18,710(D) | View → |
| Sep 18, 2026 | Sep 18 8:02 PM | Joshua T BrummDirector, Chief Executive Officer | Sale | 7,837 | $16.71 | $131.0K | 271,765(D) | View → |
| Sep 16, 2026 | Sep 18 8:02 PM | Joshua T BrummDirector, Chief Executive Officer | Sale | 1,610 | $17.90 | $28.8K | 279,602(D) | View → |
| Sep 18, 2026 | Sep 18 8:01 PM | Jonathan McneillPresident and COO | Sale | 3,839 | $16.71 | $64.1K | 134,588(D) | View → |
| Sep 16, 2026 | Sep 18 8:01 PM | Jonathan McneillPresident and COO | Sale | 731 | $17.90 | $13.1K | 138,427(D) | View → |
| Sep 18, 2026 | Sep 17 8:33 PM | Joshua T Brumm | Proposed Sale | 9,013 | $17.18 | $154.8K | — | View → |
| Sep 18, 2026 | Sep 17 8:32 PM | Jonathan McNeill | Proposed Sale | 4,415 | $17.18 | $75.8K | — | View → |
| Sep 16, 2026 | Sep 16 7:09 PM | Jonathan McNeill | Proposed Sale | 804 | $18.80 | $15.1K | — | View → |
| Sep 16, 2026 | Sep 16 7:09 PM | Joshua T Brumm | Proposed Sale | 1,771 | $18.80 | $33.3K | — | View → |
| Jul 16, 2026 | Jul 20 9:30 PM | Fairmount Funds Management LLCDirector, 10% Owner | Purchase | 853,450 | $14.50 | $12.4M | 3,601,316(I) | View → |
| Jun 22, 2026 | Jun 23 8:04 PM | Ryan LynchTreasurer, Senior Vice President of Finance and Chief Accounting Officer. | Sale | 465 | $17.99 | $8.4K | 13,871(D) | View → |
| Jun 22, 2026 | Jun 23 8:04 PM | Jan PinkasChief Scientific Officer | Sale | 1,288 | $17.99 | $23.2K | 22,239(D) | View → |
| Jun 22, 2026 | Jun 23 8:03 PM | Richard William ScalzoChief Financial Officer | Sale | 1,112 | $17.99 | $20.0K | 20,298(D) | View → |
| Jun 22, 2026 | Jun 23 8:03 PM | Barbara Harlin BisphamGeneral Counsel and Corporate Secretary. | Sale | 1,218 | $17.99 | $21.9K | 19,330(D) | View → |
| Jun 22, 2026 | Jun 23 8:02 PM | Ellie Eunkyung ImChief Medical Officer | Sale | 1,219 | $17.99 | $21.9K | 22,069(D) | View → |
| Jun 22, 2026 | Jun 23 8:02 PM | Jonathan McneillPresident and COO | Sale | 20,549 | $17.99 | $369.7K | 139,158(D) | View → |
Page 1 of 2
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jul 16, 2026 | Jul 20 9:30 PM | Fairmount Funds Management LLCDirector, 10% Owner | Purchase | 525,897 | $0.001 | 2,294,037(I) | View → |
| Jun 2, 2026 | Jun 3 11:48 PM | Jonathan ViolinDirector | Grant/Award | 11,050 | $17.01 | 11,050(D) | View → |
| Jun 2, 2026 | Jun 3 11:48 PM | David Charles LubnerDirector | Grant/Award | 11,050 | $17.01 | 11,050(D) | View → |
| Jun 2, 2026 | Jun 3 11:47 PM | Alexandra BalcomDirector | Grant/Award | 11,050 | $17.01 | 11,050(D) | View → |
| Jun 2, 2026 | Jun 3 11:47 PM | Susan MoranDirector | Grant/Award | 11,050 | $17.01 | 11,050(D) | View → |
| Jun 2, 2026 | Jun 3 11:46 PM | Fairmount Funds Management LLCDirector, 10% Owner | Grant/Award | 11,050 | $17.01 | 11,050(I) | View → |